Purchases and Sales Made in Q3 2023 in Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX) during Q3 2023. The information is specifically focused on institutions that hold shares of Vaxcyte, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-16.7K- 3.75% |
$770K - $888K
|
429K
$38.6M
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-17.8K- 22.74% |
$818K - $944K
|
60.4K
$5.43M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-18.1K- 0.57% |
$830K - $959K
|
3.15M
$283M
|
|
|
Nov 06, 2023
Q3 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-31.4K- 6.78% |
$1.44M - $1.66M
|
431K
$38.7M
|
|
|
Nov 07, 2023
Q3 2023
|
New York State Common Retirement Fund
|
SELL
|
- |
-40.2K- 42.96% |
$1.85M - $2.14M
|
53.4K
$4.8M
|
|
|
Nov 13, 2023
Q3 2023
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-43.3K- 71.45% |
$1.99M - $2.3M
|
17.3K
$1.55M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-52K- 10.81% |
$2.39M - $2.76M
|
429K
$38.6M
|
|
|
Nov 14, 2023
Q3 2023
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-58K- 9.84% |
$2.67M - $3.08M
|
531K
$47.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-71.6K- 12.53% |
$3.29M - $3.8M
|
500K
$44.9M
|
|
|
Nov 13, 2023
Q3 2023
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-84.3K- 69.93% |
$3.88M - $4.48M
|
36.3K
$3.26M
|
|
|
Nov 13, 2023
Q3 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-86.6K- 36.35% |
$3.98M - $4.6M
|
152K
$13.6M
|
|
|
Nov 14, 2023
Q3 2023
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-87K- 49.15% |
$4M - $4.62M
|
90K
$8.09M
|
|
|
Nov 02, 2023
Q3 2023
|
Lisanti Capital Growth, LLC
|
SELL
|
- |
-97.8K- 73.65% |
$4.5M - $5.19M
|
35K
$3.14M
|
|
|
Nov 14, 2023
Q3 2023
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-103K- 5.97% |
$4.73M - $5.46M
|
1.62M
$146M
|
|
|
Nov 14, 2023
Q3 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-119K- 13.58% |
$5.47M - $6.31M
|
756K
$67.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-140K- 50.0% |
$6.44M - $7.43M
|
140K
$12.6M
|
|
|
Oct 18, 2023
Q3 2023
|
Medicxi Ventures Management (Jersey) LTD
|
SELL
|
- |
-266K- 20.19% |
$12.2M - $14.1M
|
1.05M
$94.3M
|
|
|
Nov 14, 2023
Q3 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-271K- 16.81% |
$12.5M - $14.4M
|
1.34M
$121M
|
|
|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-275K- 33.77% |
$12.6M - $14.6M
|
538K
$48.4M
|
|
|
Nov 14, 2023
Q3 2023
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-278K- 11.72% |
$12.8M - $14.8M
|
2.09M
$188M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-423K- 76.8% |
$19.4M - $22.4M
|
128K
$11.5M
|